MSTR vs REGN · rev $477.2M vs P/E 14, rev $14.34B
MicroStrategy Incorporated (MSTR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
MicroStrategy Incorporated (MSTR) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MSTR revenue for 2025-12-31 was $477.2M. Net income was -$3.85B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. MSTR currently screens at market cap $52.71B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MSTR currently screens at market cap $52.71B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MSTR and REGN stock pages for the full models.
Not investment advice.